¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

½ÉÀå´ë»çÁõÈıºÇÐȸ 2022 5th APCMS (Asia-Pacific CardioMetabolic Syndrome) CONGRESS(1ÀÏÂ÷) : 2022-04-29

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
½ÉÀå´ë»çÁõÈıºÇÐȸ 2022 5th APCMS (Asia-Pacific CardioMetabolic Syndrome) CONGRESS(1ÀÏÂ÷) : 2022-04-29
±³À°ÀÏÀÚ : 2022-04-29
±³À°Àå¼Ò : Conrad Hotel Seoul (5F PARK BALLROOM)  
±³À°ÁÖÁ¦ : 2022 5th APCMS (Asia-Pacific CardioMetabolic Syndrome) CONGRESS(1ÀÏÂ÷)
ÁÖÃÖ±â°ü : ´ëÇѽÉÀåÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ½ÉÀå´ë»çÁõÈıºÇÐȸ  
´ã´çÀÚ : ±è¼±¿Á
¿¬¶ôó : 02-2273-8556  
À̸ÞÀÏ : apcms@kscms.org      
±³À°Á¾·ù : ³»°ú      
Âü¼®¿¹»óÀοø : 200¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 7 ½Ã°£ 15ºÐ  
¼¼ºÎ¼ö°­·á : 200,000¿ø      
ºñ°í Á¶±â»çÀüµî·Ï/Á¤±Ô»çÀüµî·Ï/ÇöÀåµî·Ï(Foreign:50USD)(Domestic M.D. / Ph.D.:180,000/190,000/200,000 KRW)(Domestic Student/Nurse/Medical Representatives/Resident, etc.:30,000KRW)      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 04-29 Room 1 09:00~09:16 Associations Between Body Fat Parameters and Arterial Stiffness  ±èÇзÉ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 04-29 Room 1 09:16~09:32 Predictors of Metabolic Syndrome in Patients With RA: Clinic Based Case-Control Study  Shukhrat Ziyadullaev(Samarkand State Medical Inst. Uzbekistan) 
±³À°½Ã°£ 04-29 Room 1 09:32~09:48 Knowledge, Attitude, Practice and Awareness on Complications of Hypertension Among Students and Staff in Faculty of Medicine and Health Sciences  Navin Kumar Devara(Univ. Putra Malaysia Malaysia) 
±³À°½Ã°£ 04-29 Room 1 09:48~10:04 Effects of Zinc Oxide Nanoparticles on Oxidative Stress and Renal Function in Fat-Fed and Streptozotocin-Treated Rats  Pardeep Kumar(F H Medical College India) 
±³À°½Ã°£ 04-29 Room 1 10:04~10:20 Hemo-Metabolic Crisis in Patients With ST-Segment Elevation Myocardial Infarction Data From INTERSTELLA Registry  °ø¹Î±Ô(¼øõÇâÀÇ´ë) 
Åä·Ð 04-29 Room 1 10:20~10:40 Discussion  ¿À±Ôö(Ä«Å縯ÀÇ´ë) 
±³À°½Ã°£ 04-29 Room 1 11:00~11:20 PCSK9 Inhibitors  ±âÀ¯Á¤(À»ÁöÀÇ´ë) 
±³À°½Ã°£ 04-29 Room 1 11:20~11:40 Recent Insights of SGLT2 Inhibitors in the Care of Cardiometabolic Syndrome  Atsushi Tanaka(Saga Univ. Japan) 
±³À°½Ã°£ 04-29 Room 1 11:40~11:50 GLP-1RA  ±è¿øÁø(Â÷ÀÇ°ú´ëÇÐ) 
±³À°½Ã°£ 04-29 Room 1 11:50~12:00 ARNI  ¹ÚÁøÁÖ(¼­¿ïÀÇ´ë) 
Åä·Ð 04-29 Room 1 12:00~12:20 Discussion  ¹®Àαâ(¼øõÇâÀÇ´ë) 
±³À°½Ã°£ 04-29 Room 1 13:25~14:05 New Approaches to Treating Metabolic Diseases and CVD Based on Clinical Trials  Robert H. Eckel(Univ. of Colorado USA) 
Åä·Ð 04-29 Room 1 14:05~14:25 Q&A  Robert H. Eckel(Univ. of Colorado USA) 
±³À°½Ã°£ 04-29 Room 1 14:30~14:45 Statin  À̹ÎÈ£(¼øõÇâÀÇ´ë) 
±³À°½Ã°£ 04-29 Room 1 14:45~15:00 PCSK-9 Inhibitors  ÃÖ¼ºÈÆ(ÇѸ²ÀÇ´ë) 
±³À°½Ã°£ 04-29 Room 1 15:00~15:15 Ezetimibe  Á¤ÀçÈÆ(±¹¸³Áß¾ÓÀÇ·á¿ø) 
±³À°½Ã°£ 04-29 Room 1 15:15~15:30 Colchicine  ¹ÚÈÆÁØ(°¡Å縯ÀÇ´ë) 
Åä·Ð 04-29 Room 1 15:30~15:45 Discussion  ±âÀ¯Á¤(À»ÁöÀÇ´ë) 
±³À°½Ã°£ 04-29 Room 1 16:00~16:40 Remnant Cholesterol  B©ªrge Nordestgaard(Univ. of Copenhagen Denmark) 
Åä·Ð 04-29 Room 1 16:40~16:45 Q&A  B©ªrge Nordestgaard(Univ. of Copenhagen Denmark) 
±³À°½Ã°£ 04-29 Room 1 16:50~17:05 Home BP Monitoring  ¹ÚÀçÇü(Ãæ³²´ë) 
±³À°½Ã°£ 04-29 Room 1 17:05~17:20 Management of Young Age Hypertension  ±èÇöâ(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 04-29 Room 1 17:20~17:35 Thiazide vs Thiazide-Like: Which Diuretic Should We Choose?  ¾ÈÈ¿¼®(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 04-29 Room 1 17:35~17:50 Digital therapy on hypertension  ÀÌÇØ¿µ(¼­¿ïÀÇ´ë) 
Åä·Ð 04-29 Room 1 17:50~18:05 Discussion  ±è¹Î°ü(¿¬¼¼ÀÇ´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ½ÉÀå´ë»çÁõÈıºÇÐȸ 2022 5th APCMS (Asia-Pacific CardioMetabolic Syndrome) CONGRESS(1ÀÏÂ÷) : 2022-04-29""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇÑ°ñÀýÇÐȸ Á¦48Â÷ Çмú´ëȸ(1ÀÏÂ÷) : 2022-04-29
´ÙÀ½±Û (¿Â¶óÀÎ) 2022 ´ëÇÑÀÓ»ó¾à¸®ÇÐȸ Ãá°èÇмú´ëȸ : 2022-04-29
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
564 ¼­¿ï °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ ¾È°úÇб³½Ç Áý´ãȸ : 2018-09-06 0 815 2018-08-29
563 °æ±â ¾ÆÁÖ´ëÇк´¿ø ºñ´¢ÀÇÇаú Áö¿ªÀÇ»çÁý´ãȸ : 2018-09-06 1 739 2018-08-29
562 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø 2018³â ´ëÇѼöÇ÷ÇÐȸ ÇмúÁý´ãȸ : 2018-09-06 0 653 2018-08-29
561 ÀÎõ °¡ÃµÀÇ´ë±æº´¿ø °íÀ§Çè »ê¸ð½Å»ý¾Æ ÅëÇÕÄ¡·á¼¾ÅÍ ¿ªÇÒ ¹× ¿î¿µ¹æÇâ : 2018-09-06 [2] 0 1,241 2018-08-29
560 ¼­¿ï °í´ë¾È¾Ïº´¿ø ¼Ò¾Æû¼Ò³â°ú ¿ù·Ê Áý´ãȸ : 2018-09-05 0 770 2018-08-29
559 °æ±â ´ëÇÑÀÓ»ó°Ë»çÁ¤µµ°ü¸®ÇÐȸ 2018³âµµ Ãß°èÇмú´ëȸ : 2018-09-05 0 1,294 2018-08-29
558 ¼­¿ï ¼­¿ï¾Æ»êº´¿ø Á¦ 3Â÷ °³¿øÀǸ¦ À§ÇÑ ´ëÇѺÎÁ¤¸ÆÇÐȸ ¿¬¼ö±³À° : 2018-09-04 0 1,136 2018-08-29
557 ºÎ»ê ´ëÇѺ´¸®ÇÐȸ ºÎ»ê¿ï»ê°æ³²Áöȸ À¯¹æ ¹× ºñ´¢»ý½Ä±â°è º´¸®ÀÇ ÃÖ½ÅÁö°ß : 2018-09-04 0 889 2018-08-29
556 ¼­¿ï ´ëÇѽŰæÁßÀçÄ¡·áÀÇÇÐȸ ¿ù·ÊÁý´ãȸ : 2018-09-04 0 937 2018-08-29
555 ¼­¿ï Á¦37ȸ ´ëÇѹ̿ë¿Ü°úÇÐȸ Ãß°èÇмú´ëȸ : 2018-09-02 0 1,913 2018-08-29
554 ¼­¿ï Á¦ 4ȸ ´ëÇѰ˾ÈÇÐȸ ±¼Àý°Ë»ç¿Í ¾È°æó¹æ Workshop : 2018-09-30 0 1,011 2018-08-22
553 ºÎ»ê 2018³â ºÎ»ê¿ï»ê°æ³² ½Å°æ°úÁöȸ Ãß°èÇмú´ëȸ : 2018-09-29 0 1,138 2018-08-22
552 ¼­¿ï °¡Å縯´ëÇб³¼­¿ï¼º¸ðº´¿ø °³¿øÀÇ ¿¬¼ö±³À°(ÁßÀÌ¿°) : 2018-09-28 0 1,262 2018-08-22
551 ¼­¿ï ¿øÀڷº´¿ø Á¦38ȸ°³¿øÀÇ ¿¬¼ö°­ÁÂ(È£Èí±âÁúȯ) : 2018-09-20 0 2,231 2018-08-22
550 ´ë±¸ ÆÄƼ¸¶º´¿ø ´ë±¸°æºÏÇ÷¾×ÁöºÎÇÐȸ : 2018-09-19 0 857 2018-08-22
1341 | 1342 | 1343 | 1344 | 1345 | 1346 | 1347 | 1348 | 1349 | 1350
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷